Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3875-3878

  Maesawa, Chihaya ^a   Tamura, Gen ^a   Nishizuka, Satoshi ^a   Ogasawara, Satoshi ^a   Ishida, Kaoru ^a   Terashima, Masanori ^a   Sakata, Ken ^a   Sato, Nobuhiro ^a   Saito, Kazuyoshi ^a   Satodate, Ryoichi ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; DNA METHYLATION; DNA SEQUENCE; ESOPHAGUS CARCINOMA; FRAMESHIFT MUTATION; GENE ACTIVATION; GENE DELETION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SILENT GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; SQUAMOUS CELL CARCINOMA;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMOZYGOTE; HUMANS; LYMPHATIC METASTASIS; METHYLATION; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 9444268107     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., and Carson D. A. Deletion of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond), 368: 753-756, 1994.
2. Serrano, M., Hannon, G. J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
3. Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stocken, E., Day, R. S., III, Johnson, B. E., and Skolnick, M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 246: 436-440, 1994.
4. Cairns, P., Polascik, T J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nat. Genet., 11: 210-212, 1995.
5. Merlo, A., Herman, J. G., Mao, L., Lee, D. J , Gabrielson, E., Burger, P. C., Baylin, S B., and Sidransky, D 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTSI in human cancers. Nat. Med , 1: 686-692, 1995.
6. Herman, J. G., Merlo, A., Mao, L , Lapidus, R. G., Issa, J-P. J., Davidson, N. E., Sidransky, D., and Baylin, S. B. Inactivation of the CDKN2/p16/MTSI gene is frequently associated with aberrant DNA methylation in all human cancers. Cancer Res., 55: 4525-4530, 1995.
7. Gonzalez-Zulueta, M., Bender, C. M., Yang, A. S , Nguyen, T., Bean, R. W., Van Tomout, J. M., and Jones, P. A. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
8. Mori, T , Miura, K., Aoki, T , Nishihira, T., Mon, S., and Nakamura, Y Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54: 3396-3397, 1994
9. Zhou, X., Tarmin, L., Yin, J., Jiang, H-Y., Suzuki, H., Rhyu, M-G , Abraham, J. M., and Meltzer, S. J. The MTSI gene is frequently mutated in primary human esophageal tumors. Oncogene, 9: 3737-3741, 1994.
10. Igaki, H., Sasaki, H., Tachimori, Y , Kato, H , Watanabe, H., Kimura, T , Harada, Y., Sugimura, T., and Terada, M Mutation frequency of the p16/CDKN2 gene in primary cancers in the upper digestive tract Cancer Res., 203: 3421-3423, 1995.
11. INK4 in human cancer. Proc. Natl. Acad Sci. USA, 91: 11045-11049, 1994.
12. Igaki, H , Sasaki, H., Kishi, T., Sakamoto, H., Tachimori, Y., Kato, H., Watanabe, H , Sugimura, T., and Terada, M. Highly frequent homozygous deletion of the p16 gene in esophageal cancer cell line Biochem. Biophys. Res. Commun , 203: 1090-1095, 1994.
13. Liu, Q., Neuhausen, S., McClure, M., Frye, C , Weaver-Feldhaus, J., Gruis, N A , Eddington, K , Allalunis-Tumer, M J , Skolnick, M. H., Fujimura, F. K., and Kamb, A. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene, 10: 1061-1067, 1995
14. Zhou, X., Suzuki, H., Shirrtada, Y., Imamura, M , Yin, J., Jiang, H-Y., Tarmin, L., Abraham, J., and Meltzer, S. J. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes m esophageal squamous carcinoma cell lines. Genes Chromosomes Cancer, 13: 285-290, 1995
15. Sakata, K., Tamura, G., Maesawa, C., Suzuki, Y., Terashima, M., Satoh, K , Eda, Y., Suzuki, A., Sekiyama, S., and Satodate, R. Loss of heterozygosity on the short arm of chromosome 9 without p16 mutation in gastric carcinomas. Jpn. J. Cancer Res., 86: 333-335, 1995.
16. Cairns, P., Tokino, K., Eby, Y , and Sidransky, D. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res , 54: 1422-1424, 1994.
17. Harada, H , Kondo, T., Ogawa, S., Tamura, T., Kitagawa, M., Tanaka, N., Lamphier, M. S., Hirai, H., and Taniguchi, T. Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia: a possible mechanism of tumor suppressor inactivation. Oncogene, 9: 3313-3320, 1994.
18. Walker, D G., Duan, W., Popovic, E. A., Kaye, A. H., Tomlinson, F. H., and Lavin, M. Homozygous deletion of the multiple tumor suppressor gene 1 in the progression of human astrocytomas. Cancer Res , 55: 20-23, 1995.
19. INK4B/ MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55: 1448-1451, 1995.
20. Nakagawa, K., Conrad, N. K., Williams, J. P , Johnson, B E., and Kelley, M. Mechanism of inactivation of CDKN2 and MTS2 genes in non-small cell lung cancer and association with advanced stage. Oncogene, 11: 1843-1851, 1995.
21. Kelly, M J., Nakagawa, K., Steinberg, S. M , Mulshine, J. L., Kamb, A., and Johnson, B. E. Differential mactivation of CDKN2 and Rb protein in non-small cell lung cancer cell lines J. Natl. Cancer Inst., 87: 756-761, 1995.
22. Reed, J. A., Loganzo, F., Jr , Shea, C. R., Walker, G J., Flores, J. F., Glendening, J. M., Bogdany, J. K., Shiel, M J., Haluska, F G , Fountain, J W., and Albino, A. P. Loss of expression of p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res., 55: 2713-2718, 1995.
23. INK4B1. Cancer Res, 56 722-727, 1996.
24. Yoshiura, K., Kanai, Y , Ochiai, A , Shimoyama, Y., Sugimuta, T., and Hirohashi, S. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc. Natl. Acad. Sci. USA, 92: 7416-7419, 1995.
25. Graff, J. R., Herman, J. G., Lapidus, R. G., Chopra, H., Xu, R., Jarrard, D. F., Isaacs, W B , Pitha, P M , Davidson, N E , and Baylin, S. B. E-Cadherin expression is silenced by DNA hypermethylation in human breast and prostatic carcinomas. Cancer Res, 55: 5195-5199, 1995.
26. Herman, J. G , Latiff, F , Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D-S., Gnarra, J. R., Linehan, W. M., and Baylin, S B. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA, 91: 9700-9704, 1994.